PX1 Research provides laboratory-grade KPV (Lysine-Proline-Valine) synthesized under strict quality controls for academic and institutional research. Our analytical-grade tripeptide is verified by HPLC and Mass Spectrometry to guarantee maximum purity, lot-to-lot consistency, and ultra-low endotoxin levels for demanding in vitro and preclinical models.
PX1 Research provides laboratory-grade KPV (Lysine-Proline-Valine) synthesized under strict quality controls for academic and institutional research. Our analytical-grade tripeptide is verified by HPLC and Mass Spectrometry to guarantee maximum purity, lot-to-lot consistency, and ultra-low endotoxin levels for demanding in vitro and preclinical models.
When sourcing high-purity KPV for sale, principal investigators and laboratory managers require consistent peptide sequence integrity, analytical transparency, and dependable batch uniformity. KPV is a tripeptide corresponding to the C-terminal amino acid sequence of alpha-Melanocyte-Stimulating Hormone (α-MSH). In preclinical literature, this fragment retains the potent anti-inflammatory sequence dynamics of the parent hormone without inducing melanogenesis.
PX1 Research manufactures KPV via solid-phase peptide synthesis (SPPS) in GMP-compliant facilities based in the United States. To meet the stringent requirements of cellular and molecular biology protocols, our KPV 10mg vials undergo rigorous purification workflows. Each batch is subjected to dual high-performance liquid chromatography (HPLC) and mass spectrometry (MS) screening to confirm a sequence purity exceeding 98%. Researchers evaluating mucosal barrier function or cellular signal transduction can rely on PX1 Research for fully validated reagents.
KPV is a tripeptide with the chemical sequence L-Lysyl-L-prolyl-L-valine (Lys-Pro-Val). Derived from the C-terminus of α-MSH (amino acids 11–13), this shortened peptide exhibits a molecular weight of approximately 341.45 g/mol. Despite its compact structure, the Lys-Pro-Val motif plays a crucial structural role in nuclear transport and cell membrane signaling pathways.
In contrast to full-length melanocortin peptides, KPV lacks the central His-Phe-Arg-Trp core motif necessary for binding and activating classical melanocortin 1 receptors (MC1R) involved in skin pigmentation. Consequently, KPV offers researchers a targeted tool to isolate the anti-inflammatory mechanisms of alpha-MSH analogs without confounding pigmentary or steroidal downstream effects. Its low molecular weight also facilitates enhanced cellular permeability in monolayer tissue cultures and ex vivo explant models.
The primary biological activity of KPV centers on its ability to cross cell membranes and interact with intracellular signaling cascades. Preclinical in vitro assays demonstrate that KPV enters epithelial and immunocompetent cells—such as macrophages and dendritic cells—via PepT1 (peptide transporter 1) endocytosis.
Once inside the cytoplasm, KPV directly interacts with key inflammatory pathways. Research indicates that KPV inhibits the translocation of Nuclear Factor kappa B (NF-κB) into the cell nucleus. By preventing p65 NF-κB subunit migration, KPV downregulates the transcription of major pro-inflammatory cytokines, including Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α). In vitro models of inflammatory challenge show significant reductions in inducible nitric oxide synthase (iNOS) expression following KPV treatment, illustrating its robust capacity to attenuate oxidative stress and inflammatory signalling cascades.
A substantial portion of published research on KPV focuses on its therapeutic potential in gastrointestinal inflammation and mucosal homeostasis. In rodent models of dextran sulfate sodium (DSS)-induced colitis, researchers have utilized KPV to assess mucosal repair, tissue regeneration, and histological recovery.
Preclinical data suggest that KPV upregulates tight junction proteins—specifically Claudin-1, Occludin, and ZO-1—thereby reinforcing the structural integrity of the intestinal epithelial barrier. Additionally, KPV administration in murine colitis models has been correlated with reduced neutrophilic infiltration (measured via myeloperoxidase activity) and decreased macroscopic mucosal damage. Laboratory investigators studying inflammatory bowel disease (IBD) pathways utilize high-purity KPV to explore non-steroidal methods for dampening gut mucosal hyper-reactivity. For comprehensive trial designs, researchers often reference our expanded peptide research library to evaluate baseline parameters across gut-derived bio-peptides.
In experimental models evaluating gut barrier integrity, wound healing, and tissue inflammation, researchers frequently compare or combine KPV with other specialized signaling molecules. Understanding the distinct mechanisms of these compounds allows investigators to structure highly specific comparative or synergistic study designs.
While KPV functions primarily through intracellular NF-κB inhibition and PepT1-mediated epithelial transport, BPC-157 operates predominantly through angiogenic activation, focal adhesion kinase pathway modulation, and growth factor upregulation. Conversely, antimicrobial host-defense peptides like LL-37 target bacterial membrane disruption and chemoattractant signaling, whereas Larazotide acts specifically as a tight junction regulatory antagonist against zonulin-mediated permeability. Comparing KPV alongside these compounds within gastrointestinal research peptides protocols provides researchers with a multifaceted toolkit for dissecting complex inflammatory cascades.
Purchasing research compounds requires absolute confidence in product purity, chemical identity, and biological safety. Unverified peptide preparations containing TFA salts, truncated sequences, or residual organic solvents can confound experimental outcomes and invalidate statistical data.
PX1 Research subjects every synthesized lot of KPV to strict analytical testing executed by an independent, ISO 17025-accredited laboratory. Our quality assurance standard includes:
• High-Performance Liquid Chromatography (HPLC): Confirms sequence purity levels ≥98%, identifying and quantifying minor peptide impurities.
• Mass Spectrometry (MS): Verifies exact molecular mass and ionization profile, confirming sequence fidelity.
• Bacterial Endotoxin Testing (LAL Assay): Ensures endotoxin levels remain below strictly controlled thresholds (<0.01 EU/mg), eliminating risk of non-specific immune activation in delicate cell cultures.
• Residual Solvent & Heavy Metal Screening: Guarantees freedom from synthesis contaminants like piperidine or acetonitrile.
Every batch of KPV 10mg lyophilized powder comes paired with a lot-specific Certificate of Analysis (COA) accessible directly online for lab compliance documentation.
To maintain the structural stability and bioactivity of lyophilized KPV, strict handling protocols must be observed upon arrival at the research facility. Lyophilized KPV powder is shipped in vacuum-sealed glass vials under an inert argon atmosphere to prevent moisture absorption and oxidative degradation.
Upon delivery, unopened vials should be stored in a freezer maintained at -20°C or -80°C for long-term stability. Prior to reconstitution, vials must be allowed to equilibrate to room temperature to prevent condensation inside the container. KPV is readily soluble in sterile bacteriostatic water, phosphate-buffered saline (PBS), or cell culture media. For in vitro applications sensitive to preservative agents, sterile 0.9% sodium chloride or sterile water for injection is recommended. Once reconstituted, liquid aliquots should be used immediately or stored at -20°C in single-use volumes to prevent repeated freeze-thaw cycles, which can induce physical peptide aggregation.
PX1 Research streamlines the procurement process for academic institutions, biotechnology firms, and contract research organizations (CROs). We understand that protocol timelines rely heavily on uninterrupted reagent supply chains.
When purchasing KPV for sale through PX1 Research, orders submitted before 3:00 PM EST (Monday–Friday) ship the same day from our domestic distribution hubs in California and Arizona. Vials are packaged in temperature-stable insulated containers to ensure cold-chain safety during transit. Laboratories requiring bulk reagent quantities or custom vial fills can establish institutional accounts via our bulk research peptide accounts portal to secure dedicated lot reserves and tiered pricing schedules.
What purity level is guaranteed when purchasing KPV for sale at PX1 Research?
Every lot of KPV offered by PX1 Research is verified by HPLC and Mass Spectrometry to guarantee a minimum sequence purity of 98.0%. A lot-specific Certificate of Analysis (COA) is provided with each shipment.
What is the primary molecular mechanism evaluated in KPV preclinical research?
KPV is primarily studied for its ability to enter cells via PepT1 transporters and inhibit the nuclear translocation of the p65 subunit of NF-κB, thereby suppressing downstream pro-inflammatory cytokine production (such as TNF-α, IL-1β, and IL-6).
How should lyophilized KPV be stored upon delivery to the lab?
Lyophilized KPV should be stored at -20°C or lower in a dry environment protected from light. Under these conditions, the desiccated peptide remains stable for up to 24 months.
Does PX1 Research conduct endotoxin testing on KPV batches?
Yes. All KPV batches undergo Chromogenic LAL assay testing to confirm endotoxin levels are maintained below <0.01 EU/mg, preventing unwanted immune system activation during sensitive cell culture or animal assays.
What reconstituting diluents are suitable for KPV in laboratory protocols?
KPV is highly soluble in sterile bacteriostatic water, sterile 0.9% saline, or cell-culture-grade phosphate-buffered saline (PBS, pH 7.4). The choice of diluent depends on the specific in vitro or ex vivo model requirements.
How does KPV differ functionally from full-length alpha-MSH?
While full-length alpha-MSH acts on melanocortin receptors (MC1R–MC5R) to induce both anti-inflammatory and melanogenic effects, KPV (the C-terminal tripeptide) acts via receptor-independent intracellular mechanisms to suppress NF-κB without activating pigmentary pathways.
Are bulk institutional quantities of KPV available for large-scale studies?
Yes. PX1 Research provides institutional supply contracts, bulk gram-scale synthesis, and custom lot reservation through our wholesale client services.
Where does PX1 Research ship KPV from, and what are the fulfillment times?
All orders are fulfilled directly from our US-based logistics centers located in California and Arizona. Orders placed prior to 3:00 PM EST, Monday through Friday, ship the same day.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.